Pharmakrysto Ltd
11026620
Some Concerns
- No accounts filed in last 18 months (-5)
- Negative net worth (-10)
- Current liabilities exceed current assets (-10)
- Going concern doubt noted in accounts (-10)
Details
Compliance
Accounts
Confirmation statement
Industry
Officers
director · Since 23/10/2017
DIRECTOR
BRITISH · UNITED KINGDOM · Age 59
Also on 2 other boards
director · Since 23/10/2017
DIRECTOR
BRITISH · UNITED KINGDOM · Age 57
Also on 1 other board
director · Since 06/11/2023
DIRECTOR
BRITISH · ENGLAND · Age 63
Also on 1 other board
CompanyRankvs 532+ SIC 21100 peers29
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Risk deductions
Going concern doubt: -10 pts
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Going Concern Doubt
existence for the foreseeable future. However, the directors are aware of certain material uncertainties which may cause doubt on the company's ability to continue as a going concern. 1.3 Research and development expenditure Research expenditure is written off against profits in the year in which it is incurred. Identifiable development expenditure is capitalised to the extent th
Key FinancialsYear ending 31/10/2024
Net Worth
-£255k
Balance sheet strength
Cash
£5k
Cash in the bank
Net Current Assets
-£251k
Working capital
Current Assets
£20k
Current Liabilities
£271k
Debtors
£15k
Tax at Year End
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2024 | 0.08 | +£44k |
| 2023 | 0.06 | +£65k |
| 2022 | 0.22 | -£11k |
| 2021 | 0.02 | -£220k |
| 2020 | 0.06 | -£175k |
Derived from filed accounts. Not audited figures.